A Multicentre, Parallel Arm, Open-label Trial of Frontline R-CHOP/Pola-RCHP and Glofitamab in Younger, Higher Risk Patients With Diffuse Large B Cell Lymphoma (DLBCL)
PHASE1
This is an open label, multi-centre, phase Ib/II, parallel arm study evalua...
Double-T - Improving Outcomes in High-risk 2nd Line Relapsed/Refractory Large B-Cell Lymphoma Patients Eligible for CAR-T-cell Therapy With a Glofitamab-based Induction and Consolidation Concept
PHASE2
The Double-T trial is a prospective, randomized, single-arm, open-label, mu...
Status
Not Yet Recruiting
Location
Universitätsklinikum Heidelberg - Innere Medizin V